Thomas X Neenan

Dr. Thomas X. Neenan is CEO and a founder of AbFero Pharmaceuticals. Prior to launching AbFero, Dr. Neenan was a founder and CEO of Sideris Pharmaceuticals. He also was co-founder and CSO of Panbela Therapeutics (NASDAQ: PBLA), formerly Sun BioPharma, and held executive roles at GelTex Pharmaceuticals and Genzyme. Before joining the biotech industry, Dr. Neenan led a research group focused on materials chemistry at AT&T Bell Labs. He holds a BSc (Hons) in chemistry and mathematics from University College Dublin, a PhD in materials chemistry from Penn State University, and completed his post-doctoral studies in chemistry with George H. Whitesides at Harvard University.